Jacob Laubach, Md

This study tests whether adding the investigational drug isatuximab to a standard four-drug regimen can improve outcomes for people newly diagnosed with multiple myeloma. About 52 adults aged 75 or younger will receive the combination before a stem cell transplant. The main goal …